Search research articles
Contact Us
Filters
Showing results (41-50 of 157) with videos related to
Page
of 16
Sort By:
The Lancet. Gastroenterology & Hepatology
|
March 12, 2022
Oral faecal microbiota transplantation in ulcerative colitis - Authors' reply
Craig Haifer, Sudarshan Paramsothy, Nadeem O Kaakoush, et al.
Digestive Diseases and Sciences
|
July 19, 2017
Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models
Fadi H Mourad, Yunki Yau, Valerie C Wasinger, et al.
Expert Opinion on Biological Therapy
|
December 24, 2013
Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases
Payal Saxena, Guang Chen, Bilel Jideh, et al.
Neurogastroenterology and Motility
|
June 25, 2020
The timed barium swallow and its relationship to symptoms in achalasia: Analysis of surface area and emptying rate
Santosh Sanagapalli, Andrew Plumb, John Maynard, et al.
Inflammatory Bowel Diseases
|
September 29, 2018
The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios
Christian P Selinger, Alvin Odouri Ochieng, Varun George, et al.
Endoscopy International Open
|
January 19, 2018
Expert-led didactic versus self-directed audiovisual training of confocal laser endomicroscopy in evaluation of mucosal barrier defects
Roy Huynh, Matthew Ip, Jeff Chang, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2024
Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
Thanaboon Chaemsupaphan, Rupert W Leong, Niels Vande Casteele, et al.
Journal of Gastroenterology and Hepatology
|
December 23, 2011
When to use biological agents in inflammatory bowel disease
Crispin Corte, Payal Saxena, Stephen Tattersall, et al.
Alimentary Pharmacology & Therapeutics
|
July 11, 2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease
John David Chetwood, Arteen Arzivian, Yvonne Tran, et al.
BMJ Open
|
October 3, 2023
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 157) with videos related to
Sort By:
Page
of 16
The Lancet. Gastroenterology & Hepatology
|
March 12, 2022
Oral faecal microbiota transplantation in ulcerative colitis - Authors' reply
Craig Haifer, Sudarshan Paramsothy, Nadeem O Kaakoush, et al.
Digestive Diseases and Sciences
|
July 19, 2017
Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models
Fadi H Mourad, Yunki Yau, Valerie C Wasinger, et al.
Expert Opinion on Biological Therapy
|
December 24, 2013
Safety and cost benefit of an accelerated infliximab infusion protocol in the treatment of ambulatory patients with inflammatory bowel diseases
Payal Saxena, Guang Chen, Bilel Jideh, et al.
Neurogastroenterology and Motility
|
June 25, 2020
The timed barium swallow and its relationship to symptoms in achalasia: Analysis of surface area and emptying rate
Santosh Sanagapalli, Andrew Plumb, John Maynard, et al.
Inflammatory Bowel Diseases
|
September 29, 2018
The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios
Christian P Selinger, Alvin Odouri Ochieng, Varun George, et al.
Endoscopy International Open
|
January 19, 2018
Expert-led didactic versus self-directed audiovisual training of confocal laser endomicroscopy in evaluation of mucosal barrier defects
Roy Huynh, Matthew Ip, Jeff Chang, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2024
Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease
Thanaboon Chaemsupaphan, Rupert W Leong, Niels Vande Casteele, et al.
Journal of Gastroenterology and Hepatology
|
December 23, 2011
When to use biological agents in inflammatory bowel disease
Crispin Corte, Payal Saxena, Stephen Tattersall, et al.
Alimentary Pharmacology & Therapeutics
|
July 11, 2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease
John David Chetwood, Arteen Arzivian, Yvonne Tran, et al.
BMJ Open
|
October 3, 2023
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, et al.
Page
of 16